Conference
A phase Ib study of selumetinib in patients (pts) with previously untreated metastatic Non-Small Cell Lung Cancer (NSCLC) receiving standard chemotherapy: NCIC Clinical Trials Group IND.215. NCT01783197.
Authors
Nicholas GA; Goffin JR; Laurie SA; Robinson AG; Goss GD; Reaume MN; Mates M; Wheatley-Price P; Ellis PM; Juergens RA
Volume
33
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
May 20, 2015
Name of conference
51st Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer
Conference place
IL, Chicago
Conference start date
May 29, 2015
Conference end date
June 2, 2015
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
15
ISSN
0732-183X